Matthias Dürst

Professor, Head research laboratory

Universitätsklinikum Jena

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Cancer Biology Cancer Biology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Matthias Dürst is a Professor and Head of the research laboratory at Universitätsklinikum Jena, Germany. His research areas include the molecular mechanisms of cervical precancers, diagnostic accuracy of HPV integration sites, and the evaluation of methylation markers in cervical cancer treatment. He is also engaged in studies regarding the cytotoxicity of metal complexes in cancer therapy and the roles of RUNX3 transcript variants in ovarian carcinoma.

Articles (8)

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (2)

Alexander S. Mosig

Jena University Hospital

GERMANY

View details

Peter Hillemanns

Prof. Dr.

Medizinische Hochschule Hannover

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Matthias Dürst

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

Heterogeneous Distribution of Human Papillomavirus (HPV) Integration Sites in Cervical Precancers Compromises the Diagnostic Accuracy of Integrant-Specific PCR

Accuracy of GynTect<sup>®</sup> Methylation Markers to Detect Recurrent Disease in Patients Treated for CIN3: A Proof-of-Concept Case-Control Study

Evaluation of CIN2/3 Lesion Regression in GynTect<sup>®</sup> DNA Methylation-Marker-Negative Patients in a Longitudinal Study

Novel Nickel(II), Palladium(II), and Platinum(II) Complexes with <i>O</i>,<i>S</i> Bidendate Cinnamic Acid Ester Derivatives: An In Vitro Cytotoxic Comparison to Ruthenium(II) and Osmium(II) Analogues

Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms

Evidence for disseminated tumor cells in lymphatic vessels afferent to sentinel lymph nodes in patients diagnosed with cervical cancer

Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance

RUNX3 Transcript Variants Have Distinct Roles in Ovarian Carcinoma and Differently Influence Platinum Sensitivity and Angiogenesis

Collaborators (2)

Alexander S. Mosig

Peter Hillemanns

Make your next move.